Could an old gout drug help treat coronavirus? Study suggests colchicine can fight inflammation
A new study from the University of Athens in Greece found that 14% of coronavirus patients in a control group died compared to 1.8% in the group receiving colchicine, an old gout drug. (Source: the Mail online | Health)
Source: the Mail online | Health - June 24, 2020 Category: Consumer Health News Source Type: news
A 2000-year-old medicine might find its thunder amidst Covid scare
The trial involved 105 Greek patients hospitalised with Covid-19. The results suggest a significant clinical benefit from colchicine in patients who are hospitalised with Covid-19. Doctors in India say that the drug is commonly available in India and is also used in some heart conditions. (Source: The Economic Times)
Source: The Economic Times - June 24, 2020 Category: Consumer Health News Source Type: news
In Early Trial, an Ancient Drug, Colchicine, Shows Promise Against Severe COVID-19
WEDNESDAY, June 24, 2020 -- There ' s new evidence that a 2,000-year-old medicine might offer hope against a modern scourge: COVID-19.
The medication, called colchicine, is an anti-inflammatory taken as a pill. It ' s long been prescribed for gout, a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 24, 2020 Category: General Medicine Source Type: news
Effect of colchicine on biomarkers and clinical outcomes in patients hospitalized with COVID-19
(JAMA Network) This randomized clinical trial evaluates the effect of treatment with colchicine on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2020 Category: Infectious Diseases Source Type: news
Could Gout Drug Colchicine Help Fight Severe COVID-19?
WEDNESDAY, April 22, 2020 -- As researchers hunt for ways to treat severe COVID-19 infections, a new trial will ask whether an old arthritis drug can prevent serious complications in the first place.
The medication, called colchicine, is an oral... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 22, 2020 Category: General Medicine Source Type: news
Could an Ancient Drug Help Fight Severe COVID-19?
WEDNESDAY, April 22, 2020 -- As researchers hunt for ways to treat severe COVID-19 infections, a new trial will ask whether an old arthritis drug can prevent serious complications in the first place.
The medication, called colchicine, is an oral... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 22, 2020 Category: General Medicine Source Type: news
New trial will send drug to COVID-19 patients' home to see if it can prevent serious complications
A new international clinical trial will examine if colchicine, a drug most often used to treat gout, can can reduce rates of hospitalization and death caused by the novel coronavirus. (Source: the Mail online | Health)
Source: the Mail online | Health - April 21, 2020 Category: Consumer Health News Source Type: news
Adverse Events During Oral Colchicine Use Adverse Events During Oral Colchicine Use
Colchicine is commonly used in the treatment of inflammatory diseases, but what do we know about the potential adverse events associated with its use?Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 7, 2020 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Could Colchicine Be the New Aspirin? Could Colchicine Be the New Aspirin?
Michel Zeitouni talks to Jean-Claude Tardif about the COLCOT series of clinical trials testing colchicine, an anti-inflammatory gout drug, for the prevention and treatment of cardiovascular disease.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 27, 2020 Category: Consumer Health News Tags: Cardiology Expert Interview Source Type: news
What Is the Classic Clinical Presentation of Pericarditis?
Discussion
The pericardium is a bi-layered membrane that envelops the heart and provides a barrier to prevent disease and also decreases friction as the heart moves. Pericarditis is the inflammation of pericardium. The incidence is underreported as asymptomatic or mild disease may go unrecognized. From hospitalized patient data, 0.2-5% of patients with various cardiac disease had pericarditis. An incidence rate for hospitalizations of 3.32 per 100,000 person years has been cited. Percarditis occurs more often in adolescent males.
Treatment of the underlying cause or suspected cause is important, along with close monitorin...
Source: PediatricEducation.org - January 13, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Drug used to treat gout cuts odds of new heart attack, stroke in heart attack survivors
The inflammation-fighting drug colchicine, already a treatment for gout, dramatically reduces the odds of future cardiovascular problems in people who have just survived a heart attack, a large new study by a Montreal researcher has concluded. (Source: CBC | Health)
Source: CBC | Health - November 18, 2019 Category: Consumer Health News Tags: News/Health Source Type: news
Colchicine cuts odds of new heart attack, stroke in heart attack survivors
(Reuters Health) - The inflammation-fighting drug colchicine, already a treatment for gout, dramatically reduces the odds of future cardiovascular problems in people who have just survived a heart attack, a large new study has concluded. (Source: Reuters: Health)
Source: Reuters: Health - November 18, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
Cheap, Older Gout Drug Could Be a Lifesaver After Heart Attack
In the new trial, colchicine reduced by as much as 34% a heart attack survivor's combined risk of either dying from heart disease or having cardiac arrest, a heart attack, a stroke or angioplasty. (Source: WebMD Health)
Source: WebMD Health - November 18, 2019 Category: Consumer Health News Source Type: news
AHA: Risk for Ischemic CV Events Lower With Colchicine After MI
MONDAY, Nov. 18, 2019 -- Patients with recent myocardial infarction have a lower risk for ischemic cardiovascular events with colchicine versus placebo, according to a study published online Nov. 16 in the New England Journal of Medicine to coincide... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 18, 2019 Category: Pharmaceuticals Source Type: news
Colchicine Before PCI Cuts Inflammatory Markers but Not MACE Colchicine Before PCI Cuts Inflammatory Markers but Not MACE
Although colchicine did not significantly reduce major adverse cardiovascular events after PCI, the researchers are encouraged by significant decreases in markers of inflammation vs placebo.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 18, 2019 Category: Cardiology Tags: Cardiology News Source Type: news
